SCHEMBL23668186

SCHEMBL23668186

Cc1ccc(S(=O)(=O)n2cc(-c3ccnc(Cl)n3)c3ccnc(Cl)c32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 4/20 0.44
▸ FLT3 P36888 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.36
▸ UBE2N P61088 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ BCR P11274 1/20 0.36
▸ HTT P42858 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ ALDH3A1 P30838 1/20 0.35
▸ NOD1 Q9Y239 1/20 0.35
▸ DYRK1B Q9Y463 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ HSD11B1 P28845 1/20 0.34
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30810135 1.00 BRD4 (0.44) BRD4FLT3ALDH1A1L3MBTL1KDM4E
SCHEMBL23668182 0.84 ABL1 (0.39) BRD4ALDH1A1L3MBTL1KDM4EUBE2N
SCHEMBL29431172 0.83 HSD11B1 (0.40) BRD4FLT3ALDH1A1L3MBTL1KDM4E
SCHEMBL18662689 0.83 HSD11B1 (0.40) BRD4FLT3ALDH1A1L3MBTL1KDM4E
SCHEMBL23668178 0.79 FLT3 (0.42) BRD4FLT3DYRK1BIKBKBCHUK
SCHEMBL23668176 0.79 L3MBTL1 (0.42) BRD4ALDH1A1L3MBTL1KDM4EUBE2N
SCHEMBL30810137 0.79 L3MBTL1 (0.42) BRD4ALDH1A1L3MBTL1KDM4EUBE2N
SCHEMBL13051115 0.73 HTR6 (0.51) FLT3DYRK1B
SCHEMBL3819496 0.72 HTR6 (0.58) FLT3L3MBTL1
SCHEMBL23668196 0.72 L3MBTL1 (0.56) BRD4ALDH1A1L3MBTL1KDM4EUBE2N

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12234232-B2 Aromatic heterocyclic compound with kinase inhibitory activity SHANGHAI ENNOVABIO PHARMACEUTICALS CO., LTD. (CN) 2025-02-25 — — US disclosed
CN-112823159-B Aromatic heterocyclic compounds with kinase inhibitory activity 上海轶诺药业有限公司 2024-03-01 — — CN disclosed
US-20210371415-A1 AROMATIC HETEROCYCLIC COMPOUND WITH KINASE INHIBITORY ACTIVITY SHANGHAI ENNOVABIO PHARMACEUTICALS CO., LTD. (CN) 2021-12-02 — — US disclosed
EP-3854793-A1 AROMATIC HETEROCYCLIC COMPOUND WITH KINASE INHIBITORY ACTIVITY Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) 2021-07-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210371415-A1 AROMATIC HETEROCYCLIC COMPOUND WITH KINASE INHIBITORY ACTIVITY JAK1, JAK2, JAK3 BRD4 541/4885FLT3 48/4885ALDH1A1 1724/4885
US-12234232-B2 Aromatic heterocyclic compound with kinase inhibitory activity JAK1, JAK2, JAK3 BRD4 541/4885FLT3 48/4885ALDH1A1 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback